Outcomes of Curable Cancers in Vulnerable Populations
弱势群体中可治愈癌症的结果
基本信息
- 批准号:7546354
- 负责人:
- 金额:$ 2.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-10 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAfrican AmericanAge-YearsBreastCaringCensusesCessation of lifeChildhoodColonColorectalConditionCountyDataData FilesDatabasesDisadvantagedDrug FormulationsElderlyEnrollmentFemale of child bearing ageFoundationsFutureGeneral PopulationGenus ColaHealth PolicyHealth ServicesHodgkin DiseaseIncidenceIncomeInformation SystemsLinkLow incomeLungMalignant NeoplasmsMalignant neoplasm of testisMalignant neoplasm of urinary bladderMedicaidMedical SurveillanceMental disordersNon-Hodgkin&aposs LymphomaNumbersOhioOutcomePatientsPopulationPopulation StudyPsyche structureRaceRateRecordsRelapseReportingResearchRuralStagingSubgroupSurvival RateSystemVariantVulnerable Populationsbasebeneficiaryindexingmelanomaresidencesocioeconomics
项目摘要
DESCRIPTION (provided by applicant): A number of cancers, including cancer of the testis; Hodgkins and non-Hodgkins lymphoma; early- stage breast, colorectal, lung, and urinary bladder cancer; early-stage melanoma; and pediatric malignancies in adults are considered "curable", which we define as 5-year survival without relapse. While high rates of cure have been reported in the population at large, little is known about whether these rates compare uniformly across subgroups of the population; and if so, which factors contribute to lower cure rates. In the proposed studies, which focus on adults 20-50 years of age, we aim to assess survival from these cancers in the population of Ohio overall, and in the Medicaid population in particular. Medicaid beneficiaries constitute a disadvantaged subgroup of the population. This is because in addition to socioeconomic vulnerabilities, adult beneficiaries suffer from disabling physical and/or mental ailments. An exception to this is low-income women of childbearing age seeking Medicaid coverage for maternity care. In studies accounting for the entire population in the state of Ohio, we will examine variations in survival by demographic attributes, as well as Medicaid status, additional socioeconomic indicators, and county of residence. When focusing on Medicaid beneficiaries, and given the availability of claims data for that population, we will examine the likelihood of cure in the presence or absence of mental and/or physical comorbid conditions. The proposed studies will use a unique population-based database, which we will develop by linking records from the Ohio Cancer Incidence Surveillance System (OCISS), with the state Medicaid enrollment and claims files, and data from the U.S. Census. Death-related variables, available through the OCISS files, originate from the National Death Index. By identifying differentials in survival and cure rates across subgroups of the population, these studies will provide a foundation for future research endeavors aimed at identifying the specific factors contributing to such disparities. In addition, because these cancers have been rarely examined in the context of health services and disparities-related research, the proposed studies will provide an opportunity to assess methodological issues and potential difficulties in carrying out comparable studies at a larger scale and in other settings. Project Narrative: A number of cancers, including cancer of the testis; Hodgkins and non-Hodgkins lymphoma; early- stage breast, colorectal, lung, and urinary bladder cancer; early-stage melanoma; and pediatric malignancies in adults are considered "curable", which we define as 5-year survival without relapse. The proposed studies aim to determine whether favorable outcomes of curable cancers are observed uniformly across subgroups of the population in Ohio. We will examine survival outcomes by Medicaid status; and among Medicaid beneficiaries, survival and cure rates will be evaluated in the presence or absence of mental and/or physical comorbid conditions.
描述(由申请人提供):许多癌症,包括睾丸癌;霍奇金斯和非霍奇金斯淋巴瘤;早期乳腺癌、结肠直肠癌、肺癌和膀胱癌;早期黑色素瘤;以及成人的儿科恶性肿瘤,被认为是“可治愈的”,我们将其定义为5年无复发生存期.虽然在总体人群中报告了高治愈率,但人们对这些比率在人口亚组之间是否一致知之甚少;如果是这样,哪些因素导致治愈率较低。在拟议的研究中,重点是20-50岁的成年人,我们的目标是评估这些癌症在俄亥俄州人口中的生存率,特别是在医疗补助人口中。医疗补助受益人是人口中的弱势群体。这是因为除了社会经济脆弱性之外,成年受益人还患有致残性身体和/或精神疾病。这方面的一个例外是低收入育龄妇女寻求医疗补助覆盖产妇护理。在对俄亥俄州全部人口的研究中,我们将通过人口统计学属性以及医疗补助状态、其他社会经济指标和居住县来检查生存率的变化。当关注医疗补助受益人时,并考虑到该人群的索赔数据的可用性,我们将研究在存在或不存在精神和/或身体共病情况下治愈的可能性。拟议的研究将使用一个独特的基于人群的数据库,我们将通过将俄亥俄州癌症发病率监测系统(OCISS)的记录与州医疗补助登记和索赔文件以及美国人口普查的数据相关联来开发该数据库。通过OCISS档案提供的与死亡有关的变量来自国家死亡指数。通过确定不同亚组人群的生存率和治愈率的差异,这些研究将为未来的研究工作提供基础,旨在确定导致这种差异的具体因素。此外,由于这些癌症很少在保健服务和与癌症有关的研究中得到检查,拟议的研究将提供一个机会,以评估在更大规模和其他环境中进行可比研究的方法问题和潜在困难。项目叙述:许多癌症,包括睾丸癌;霍奇金斯和非霍奇金斯淋巴瘤;早期乳腺癌、结肠直肠癌、肺癌和膀胱癌;早期黑素瘤;以及成人的儿科恶性肿瘤,被认为是“可治愈的”,我们将其定义为5年无复发的生存期.拟议的研究旨在确定可治愈癌症的有利结果是否在俄亥俄州人群的亚组中均匀观察到。我们将通过医疗补助状态检查生存结果;在医疗补助受益人中,将在存在或不存在精神和/或身体共病情况下评估生存率和治愈率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SIRAN M. KOROUKIAN其他文献
SIRAN M. KOROUKIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SIRAN M. KOROUKIAN', 18)}}的其他基金
Combination of chronic conditions determining clinical relevance and resource use
慢性病的组合决定临床相关性和资源利用
- 批准号:
8727877 - 财政年份:2014
- 资助金额:
$ 2.75万 - 项目类别:
Outcomes of Curable Cancers in Vulnerable Populations
弱势群体中可治愈癌症的结果
- 批准号:
7685470 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
BREAST CANCER OUTCOMES IN A DOUBLY DISADVANTAGED POPULATION: MEDICAID BENEFICIARI
双重弱势群体的乳腺癌结果:医疗补助受益人
- 批准号:
7679537 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
BREAST CANCER OUTCOMES IN A DOUBLY DISADVANTAGED POPULATION: MEDICAID BENEFICIARI
双重弱势群体的乳腺癌结果:医疗补助受益人
- 批准号:
7488165 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
Cancer-Related Disparities in the Elderly Population
老年人口中与癌症相关的差异
- 批准号:
6797867 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
Cancer-Related Disparities in the Elderly Population
老年人口中与癌症相关的差异
- 批准号:
6929711 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
Cancer-Related Disparities in the Elderly Population
老年人口中与癌症相关的差异
- 批准号:
6687652 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
Cancer-Related Disparities in the Elderly Population
老年人口中与癌症相关的差异
- 批准号:
7118223 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
Cancer-Related Disparities in the Elderly Population
老年人口中与癌症相关的差异
- 批准号:
7276050 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Research Grant